MNOV Earnings & Financial Statements
MediciNova, Inc.
$1.47
+$0.00(+0.14%)
34
Overall
60
Value
10
Tech
34
Quality
Market Cap
$72.36M
Volume
26.84K
52W Range
$1.17 - $3.90
Target Price
$8.40
MNOV earnings and financial statements: MediciNova, Inc.'s income statement, balance sheet and cash flow statement, annual and quarterly.
MNOV Annual Financial Statements
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | $409.7K | - | $1.00M | - | $4.04M |
| Cost of revenue | $378.6K | - | - | - | - |
| Operating income | -$13.28M | -$12.68M | -$9.90M | -$14.63M | -$10.22M |
| EBITDA | -$11.97M | -$11.02M | -$8.55M | -$14.61M | -$10.19M |
| Net income | -$12.00M | -$11.05M | -$8.57M | -$14.07M | -$10.13M |
| EPS (diluted) | $-0.24 | $-0.23 | $-0.17 | $-0.29 | $-0.21 |
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total assets | $45.60M | $55.88M | $66.27M | $74.15M | $87.41M |
| Total liabilities | $4.02M | $3.37M | $3.89M | $3.91M | $3.73M |
| Shareholders’ equity | $41.59M | $52.50M | $62.38M | $70.24M | $83.68M |
| Cash and equivalents | $30.81M | $40.36M | $51.00M | $18.51M | $71.43M |
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating cash flow | -$9.81M | -$10.64M | -$7.43M | -$12.91M | -$9.38M |
| Capital expenditure | -$2.9K | -$697.00 | -$21.3K | -$5.0K | -$28.7K |
| Free cash flow | -$9.81M | -$10.64M | -$7.45M | -$12.92M | -$9.41M |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | MNOV | $1.47 | +0.1% | 26.84K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |